Search Results 421-430 of 17696 for prednisone

1. Neoadjuvant dual checkpoint blockade with PD1 and LAG-3 inhibition in resectable Non-small cell lung Cancer - Mayo Clinic

   ... prednisone equivalent. Patients requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive ...

2. Fluconazole (intravenous route) - Side effects & uses - Mayo Clinic

   Prednisone; Ramelteon; Rifapentine; Rivaroxaban; Tretinoin; Trimetrexate. Other Interactions. Certain medicines should not be used at or around the time of ...

3. Phase 1/2 Dose Escalation Study in Patients With Relapsed or Refractory Waldenstrom's Macroglobulinemia - Mayo Clinic

   Receiving chronic systemic corticosteroid therapy > 20 mg of prednisone daily. Being treated with other anti-cancer therapies (approved or investigational) ...

4. Childhood obesity - Symptoms and causes - Mayo Clinic

   Some prescription medicines can raise the risk of obesity. They include prednisone, lithium, amitriptyline, paroxetine (Paxil), gabapentin (Neurontin, Gralise, ...

5. Hydrocodone and ibuprofen (oral route) - Side effects & dosage - Mayo Clinic

   Hydrocodone is an opioid analgesic that acts on the central nervous system to relieve pain. If hydrocodone is used for a long time, it may become habit-forming ...

6. A Study to Assess the Feasibility of Folate Scan in Patients with Idiopathic Pulmonary Fibrosis - Mayo Clinic

   Immunosuppressive therapy (> 5 mg/day of Prednisone or inhaled corticosteroids); Pregnancy or breast feeding; Subject is mentally incapable of understanding ...

7. Phenobarbital (intravenous route) - Mayo Clinic

   Leucovorin; Levomethadyl; Methylprednisolone; Metoprolol; Ospemifene; Prednisone; Rufinamide; Theophylline; Tiagabine; Topiramate. Other Interactions. Certain ...

8. Inflammatory Disorder Treatment Involves Careful Medication Management - Mayo Clinic News Network

   The primary treatment for polymyalgia rheumatica is a low dose of an oral corticosteroid, such as prednisone. This usually produces relief from pain and ...

9. Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma - Mayo Clinic

   insufficiency are eligible if on a stable dose of prednisone =< 10 mg or equivalent - ELIGIBILITY CRITERIA (STEP 1): Patients must not have an uncontrolled ...

10. Study Of SX-682 Alone And In Combination With Oral Or Intravenous Decitabine In Subjects With Myelodysplastic Syndrome - Mayo Clinic

    * Subjects with a condition requiring systemic treatment with either corticosteroids (\> 10 mg daily prednisone equivalents) or other immunosuppressive ...